|
|
Other links at Articles > Internal Medicine |
| 4. |
Naftopidil Useful for Tamsulosin-Resistant BPH
|
|
|
New research reported in Urology for November indicates that treatment with naftopidil, a long-acting alpha-1-blocker, can improve nocturia and other symptoms of benign prostatic hyperplasia (BPH) in patients unsuccessfully treated with tamsulosin. Reuters Health Information
|
| 5. |
International Approvals: Isentress, WinRho SDF, Cyanokit
|
|
|
Canada has approved raltegravir tablets (Isentress) and a liquid formulation of a Rho (D) intravenous immune globulin [human] product (WinRho SDF); Europe has approved a hydroxocobalamin kit (Cyanokit). Medscape Medical News
|
|
|